|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.34 | 89.43 | 104.26 | 0.53 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pesticides & Agrochemicals
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
748.95
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 13.00 | 15.37 | 2.88 | 6.03 | 7.94 | CEPS(Rs) | 25.68 | 29.02 | 15.65 | 17.67 | 14.76 | DPS(Rs) | 10.00 | 10.00 | 10.00 | 6.00 | 8.00 | Book NAV/Share(Rs) | 94.24 | 107.20 | 101.78 | 104.89 | 156.31 | Tax Rate(%) | 24.07 | 6.74 | 49.31 | 14.31 | 16.67 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 10.70 | 11.08 | 12.56 | 11.20 | 9.69 | EBIT Margin(%) | 8.36 | 8.84 | 5.80 | 7.53 | 8.38 | Pre Tax Margin(%) | 6.02 | 6.80 | 3.38 | 5.00 | 5.61 | PAT Margin (%) | 4.57 | 6.34 | 1.71 | 4.29 | 4.68 | Cash Profit Margin (%) | 9.03 | 11.98 | 9.32 | 12.57 | 13.04 | Performance Ratios | | | | | | ROA(%) | 5.19 | 6.74 | 1.51 | 3.32 | 3.12 | ROE(%) | 12.77 | 14.71 | 2.78 | 5.76 | 5.08 | ROCE(%) | 20.38 | 17.38 | 8.26 | 8.68 | 7.76 | Asset Turnover(x) | 1.14 | 1.06 | 0.88 | 0.78 | 0.67 | Sales/Fixed Asset(x) | 2.03 | 1.59 | 1.20 | 1.13 | 1.01 | Working Capital/Sales(x) | 37.70 | 12.94 | 27.68 | 19.07 | 11.55 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 0.49 | 0.63 | 0.83 | 0.89 | 0.99 | Receivable days | 96.47 | 94.64 | 102.40 | 100.01 | 100.10 | Inventory Days | 39.39 | 47.96 | 46.31 | 53.99 | 69.92 | Payable days | 206.22 | 201.21 | 225.86 | 200.68 | 184.93 | Valuation Parameters | | | | | | PER(x) | 55.19 | 50.07 | 223.31 | 54.16 | 80.26 | PCE(x) | 27.94 | 26.52 | 41.04 | 18.47 | 43.19 | Price/Book(x) | 7.61 | 7.18 | 6.31 | 3.11 | 6.12 | Yield(%) | 1.39 | 1.30 | 1.56 | 1.84 | 0.84 | EV/Net Sales(x) | 2.86 | 3.63 | 4.41 | 2.68 | 5.81 | EV/Core EBITDA(x) | 19.53 | 22.22 | 28.78 | 15.10 | 34.59 | EV/EBIT(x) | 30.08 | 36.46 | 67.10 | 31.90 | 69.28 | EV/CE(x) | 2.99 | 3.04 | 3.27 | 1.87 | 3.62 | M Cap / Sales | 2.86 | 3.58 | 4.33 | 2.59 | 5.63 | Growth Ratio | | | | | | Net Sales Growth(%) | 14.19 | 44.99 | 17.67 | 11.33 | 19.23 | Core EBITDA Growth(%) | 2.16 | 54.75 | 1.52 | 17.68 | 2.76 | EBIT Growth(%) | 8.85 | 119.87 | -8.02 | 11.57 | -2.16 | PAT Growth(%) | -17.09 | 434.55 | -52.28 | 13.83 | -26.09 | EPS Growth(%) | -15.43 | 434.55 | -52.28 | -24.12 | -26.09 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.08 | 0.20 | 0.15 | 0.13 | 0.21 | Current Ratio(x) | 1.06 | 1.14 | 1.07 | 1.11 | 1.14 | Quick Ratio(x) | 0.87 | 0.85 | 0.78 | 0.85 | 0.79 | Interest Cover(x) | 3.57 | 4.34 | 2.40 | 2.98 | 3.03 | Total Debt/Mcap(x) | 0.01 | 0.03 | 0.02 | 0.04 | 0.03 |
|
|
|
|
|
|